Inventor · New York, NY, US

Gilla Kaplan

14Patents
3h-index
2Co-inventors
50Inventor score

Filing activity: Oct 2, 1992 → Oct 13, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US5385901A Method of treating abnormal concentrations of TNF .alpha. Human Necessities 151 Expired
US8883815B2 Treatment for cerebral palsy impaired speech in children Human Necessities 12 Active
US9682073B2 Pre-frontal cortex processing disorder gait and limb impairments treatment Human Necessities 3 Active
US10420318B2 Pre-frontal cortex processing disorder speech, gait and limb impairments treatment Human Necessities 2 Active
US10085414B2 Pre-frontal cortex processing disorder speech, gait and limb impairments treatment Human Necessities 2 Active
US9333198B2 Treatment for cerebral palsy gait impairment Human Necessities 1 Active
US9408838B2 Treatment for cerebral palsy gait impairment Human Necessities 1 Active
US9155502B2 Treatment of cerebral palsy impaired speech in children Human Necessities 0 Active
US9161718B2 Treatment of cerebral palsy impaired speech in children Human Necessities 0 Active
US9220712B2 Pharmaceutical intervention and method for treating an apraxia of speech in children Human Necessities 0 Active
US10834891B2 Pre-frontal cortex processing disorder speech gait and limb impairments treatment Human Necessities 0 Active
US9307942B2 Treatment for cerebral palsy gait impairment Human Necessities 0 Active
US11102953B2 Pre-frontal cortex processing disorder speech, gait and limb impairments treatment Human Necessities 0 Active
US9375421B2 Pharmaceutical intervention for treating an apraxia of speech in children Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.